Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
06/2005
06/22/2005EP1543003A2 Imidazo[1,2-a]pyridines
06/22/2005EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
06/22/2005EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids
06/22/2005EP1542716A1 Growth hormone releasing peptides
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors
06/22/2005EP1272200B1 Divided dose therapies with vascular damaging activity
06/22/2005EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders
06/22/2005EP1173160B1 (e)-styryl sulfone anticancer agents
06/22/2005CN1630726A Beta-lactamase/anminoglycosides modifying enzyme genes, their fusion gene and the expression products, the composition thereof, and their uses in medicine and environmental protection
06/22/2005CN1630649A Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid
06/22/2005CN1630645A 5-HT receptor ligands and uses thereof
06/22/2005CN1630642A Benzenesulfonamide derivatives
06/22/2005CN1630519A Use of anastrozole for the treatment of post-menopausal women having early breast cancer
06/22/2005CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
06/22/2005CN1630515A Compounds active at the glucocorticoid receptor II
06/22/2005CN1630512A Pharmaceutical tablet
06/22/2005CN1628854A Sustained release medicine for artificially inducing sex reversal of grouper and its preparation method
06/22/2005CN1628840A Medicine for promoting ovulation and aiding pregnancy
06/22/2005CN1628835A Chinese medicinal formulation for treating male infertility and its preparation method
06/22/2005CN1628833A Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof
06/22/2005CN1628827A Pharmaceutical composition for treating lumbago due to kidney-asthenia and its preparing process
06/22/2005CN1628804A Dysmenorrhea treating medicine
06/22/2005CN1628799A Clove leaf extract containing soft capsule and its preparation process
06/22/2005CN1628791A Chinese medicinal compound formulation for treating pelvic inflammation with improved bioavailability and drug effect and preparation process thereof
06/22/2005CN1628773A Botanical originated nim oil sperm killing formulation
06/22/2005CN1628772A Botanical originated nim oil contraception formulation
06/22/2005CN1628771A Lotion for treating gynecological disease and its preparation process
06/22/2005CN1628766A Formulation of 'Xuefu Zhuyu Decoction' and its preparation method
06/22/2005CN1628765A Cherokee rose root formulation for treating gynecological disease and its preparation process
06/22/2005CN1628763A Cassia twig and Tuckahoe formulation for treating gynecological disease and its preparation process
06/22/2005CN1628750A Yang invigorating medicine
06/22/2005CN1628729A Pharmaceutical composition and usage
06/22/2005CN1628728A Externally applied vaginal lotion used for gynecology
06/22/2005CN1628715A Method for preparing pills to dissolve mass on mammary gland
06/22/2005CN1628711A Method for preparing liquor to treat gynecological inflammation
06/22/2005CN1628660A Externally used liquid preparation containing fibrauretine and its application on genital tract, oral cavity and upper respiratory tract
06/22/2005CN1628659A Aromatase inhibitor
06/22/2005CN1628653A Medicine for trichomonas vaginalis disease
06/22/2005CN1207297C Crystalline therapeutic agent
06/22/2005CN1207295C Method for preparing pyrazo-(4, 3-d) pyrimidine-7-ketone and its intermediate
06/22/2005CN1207053C Chinese medicine for treating gynecopathy
06/22/2005CN1206998C Composition and method for treating penile erectile dysfunction
06/22/2005CN1206989C Mixed snuff prepn. for reducing side effect of Apomorphinum
06/21/2005US6909014 Intermediates for the synthesis of ether compounds
06/21/2005US6909007 Steroidal pharmaceutical compounds
06/21/2005US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors
06/21/2005US6908904 Pharmaceutical preparation and method for treatment of diabetes
06/21/2005US6908741 Receptor for advanced glycated endproducts (RAGE); solid phase synthesis; immunoassay
06/21/2005US6908614 Anti-aging/menopause symptoms relief using ganoderma lucidum spores
06/21/2005US6908432 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
06/21/2005CA2294788C Therapeutical system for transdermal delivery of levonorgestrel
06/21/2005CA2250372C 6-phenylpyridyl-2-amine derivatives
06/21/2005CA2066304C Pharmaceutical composition for the treatment of autoimmune diseases
06/16/2005WO2005054432A2 Gene transfer for regulating smooth muscle tone
06/16/2005WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor
06/16/2005WO2004099782A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39)
06/16/2005WO1990006121A8 Method for improving reproductive functions in mammals
06/16/2005US20050131238 Using substituted maleimide compound
06/16/2005US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases
06/16/2005US20050131005 4-azasteroid derivatives as androgen receptor modulators
06/16/2005US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
06/16/2005US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents
06/16/2005US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders
06/16/2005US20050129736 Compositions and methods for treating or preventing diseases of body passageways
06/16/2005CA2589908A1 Use of a cyclopentenone prostaglandin for delaying for the onset and/or preventing the continuation of labour
06/16/2005CA2589528A1 Use of a cyclopentenone prostaglandin for delaying the onset and/or preventing the continuation of labour
06/15/2005EP1541560A1 Novel tetrahydroquinoline derivatives
06/15/2005EP1541168A1 Method of regulating animal reproduction
06/15/2005EP1541162A1 Intravaginal washing agent
06/15/2005EP1541149A1 Phosphodiesterase inhibitor
06/15/2005EP1541137A2 Transdermal delivery system of hormones without penetration enhancers
06/15/2005EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
06/15/2005EP1539932A1 In vitro fertilisation
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539732A1 Novel compounds
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
06/15/2005EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
06/15/2005EP1539205A1 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof
06/15/2005EP1539191A1 Glycoalkaloid compositions and various uses thereof
06/15/2005EP1539184A1 Estrogen replacement regimen
06/15/2005EP1539165A1 Sustained-release tablet composition comprising a dopamine receptor agonist
06/15/2005EP1539096A1 New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof
06/15/2005EP1439831B1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
06/15/2005EP1330255B1 Preparation of cimicifuga racemosa for treating incontinence
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005EP1311259B1 Pharmaceutical composition comprising an ester of 5-aminolevulinic acid as photochemotherapeutic agent and a mucoadhesive agent
06/15/2005EP1259229B1 USE OF BENZO-THIENO[2,3-d]PYRIMIDINES HAVING PDE V INHIBITING ACTIVITY FOR THE TREATMENT OF ERECTILE DYSFUNCTION
06/15/2005EP1257277B1 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
06/15/2005EP1075282B1 Peg-lhrh analog conjugates
06/15/2005CN1628128A Mammal prolactin variants
06/15/2005CN1628113A Substituted indoles as alpha-1 agonists
06/15/2005CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1627938A Pharmaceutical dosage form for mucosal delivery
1 ... 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 ... 557